fda warning letters glp-1 compounding september 26 2025 COMES FOR NOVO DRAMA. #medicine #wellness #news #life #hospital Congress Introduces SAFE Drugs Act – Diabetes advocacy group discourages use

Warren, Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial

And then I had Turkey breasts for dinner every day for 10 months

The dual agonist approach represented by tirzepatide demonstrates that activating multiple complementary pathways produces superior results to targeting a single pathway, even when that single pathway works quite well on its own

Glucagon-like peptide (GLP-1) medications are giving many people with type 2 diabetes a new approach for managing their condition

This study was approved by Western University of Health Sciences Institutional Review Board (IRB)